Skip to main content

Watch Online: CSL CEO Paul Perreault's Remarks at a White House Roundtable

Perreault made the case for a plasma-based hyperimmune to treat COVID-19.


CSL Limited CEO Paul Perreault made a quick trip to Washington, D.C., last week to be part of a White House discussion about the urgent need for plasma donations from recovered COVID-19 patients. He was among 11 participants in a roundtable, which included:

President Donald Trump

Secretary of Health and Human Services Alex Azar

U.S. Surgeon General Dr. Jerome Adams

White House COVID-19 response coordinator Dr. Deborah Birx

National Institutes of Health Director Dr. Francis Collins

Director of the Institute of Allergy and Infectious Diseases Dr. Anthony Fauci

FDA Commissioner Dr. Stephen Hahn

America’s Blood Centers CEO Kate Fry

American Red Cross CEO Gail McGovern

LabCorp CEO Adam Schechter